Starting this month, national health insurance coverage will apply to the glucagon-like peptide-1 (GLP-1) class diabetes treatment Ozempic Pre-filled Pen (ingredient semaglutide) for people with type ...
Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names ...
The Trump administration’s promised direct-to-consumer drug platform TrumpRx has officially gone live, with President Trump ...
Ireland has been chosen as the manufacturing site to make the weight loss drug Wegovy in tablet form. It is currently is only available in this country to use as an injection but its maker, Novo ...
Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance sheets, and a track record of turning scientific breakthroughs into ...
Eli Lilly and Company LLY reported first-quarter 2025 adjusted earnings per share (“EPS”) of $3.34, which missed the Zacks Consensus Estimate of $3.52 per share. Earnings rose 29% year over year.
Ozempic-maker Novo Nordisk turned to the actors from Apple’s 2000s “Get a Mac” ads to differentiate its GLP-1 medication amid a rising sea of competitors. On January 20, the Danish pharmaceutical ...
Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and ...
Jan 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what ...
By Amina Niasse NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo ...
A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...
Femi Aremu, PharmD, is a Drug Information Pharmacist for Red Ventures and practiced in a COVID-19 clinic for the University of Chicago Medicine. Ozempic's blood sugar improvements may appear within a ...